Studies Eye NO Role in Red Blood Cells
Friday, February 2, 2001
Duke University Medical Center researchers report that the
membranes of red blood cells are actively involved in storing and
releasing nitric oxide, a molecule that regulates blood flow and
oxygen delivery in humans.
The findings, published in today's issue (Feb. 1) of the journal
Nature, could help improve understanding and treatment of
cardiovascular side effects associated with a number of diseases,
including diabetes and sickle cell anemia, and with medical
treatments such as blood transfusion or the use of blood
substitutes, said Dr. Jonathan Stamler, the study's principal
investigator and a professor of medicine.
"It's clear from our work that there exists a crucial relationship
between nitric oxide (NO), oxygen, hemoglobin and red blood cells
for appropriate dilation of blood vessels and delivery of oxygen to
tissues," said Stamler, also a Howard Hughes Medical Institute
investigator at Duke University Medical Center. "It's time to look
at the role of red blood cells in these diseases. Faulty
interaction of nitric oxide, hemoglobin and red blood cells may
help explain cardiovascular morbidity."
In particular, Stamler noted that recent studies elsewhere have
shown that blood transfusion and administering a drug called
erythropoeitin, which increases red blood cell production, are
associated with increases in unwanted cardiovascular side effects.
There also are documented changes in red blood cell structure and
function in sickle cell crisis, high blood pressure and pulmonary
vascular disease, he said.
"In all these instances, the red blood cells are probably deficient
in NO, and we've shown in this study that we can put NO back," he
said.
While the scientists reported in 1996 that hemoglobin binds NO
inside red blood cells, the importance of the red blood cell
membrane in releasing NO from the cell wasn't recognized until now.
The research was funded by the Howard Hughes Medical
Institute.
Due in large part to Stamler's work over the last five years, the
image of NO has changed from merely being a noxious atmospheric gas
to also being one of the most important molecules in the human
body, responsible for such vital functions as controlling blood
pressure and coordinating the expansion and contraction of blood
vessels.
A remaining question had been how NO can move from inside red blood
cells, where it is bound to the hemoglobin molecule, to outside the
blood cells where it can interact with the smooth muscle cells
surrounding the blood vessels to cause dilation of the vessels.
While both oxygen and NO can diffuse into red blood cells, only
oxygen can diffuse back out.
"We've shown that red blood cell membranes are little pumps for
nitric oxide. We've also demonstrated a different view of the
inside of red blood cells," Stamler said. "The findings point out
that red blood cells are unique and complex, and their normal
operation is of vital importance."
To solve the puzzle of NO's mobility in blood, lead author Dr. John
Pawloski and co-author and assistant professor of medicine Doug
Hess examined whole red blood cells. The laboratory's previous work
had been carried out with free hemoglobin - hemoglobin molecules
without the red blood cells that normally would contain them.
The researchers first proved that hemoglobin interacts with NO when
inside red blood cells the same way it does when "free." Most of
the hemoglobin binds NO to one of its four iron atoms - the same
places it binds oxygen - which renders the NO non-functional.
However, some of the hemoglobin binds the NO to a sulfur atom at
another specific site, creating what they called S-nitrosothiol
(SNO) when Stamler's group first described it in 1996. SNO is an
activated version of NO that maintains its function.
To localize the two hemoglobin-NO complexes in the cell, the
scientists dismantled the cells, separating the membrane portion
from almost everything else. They reported that the
oxygen-hemoglobin-SNO complex was associated predominantly with the
membrane of the red blood cells, while most of the NO-iron
hemoglobin complex was found in the non-membrane portion.
Additional experiments showed that hemoglobin and the cell membrane
interact via the bound SNO. Upon release of the hemoglobin's
oxygen, the SNO is transferred to the cell membrane, specifically
to a protein called AE1, or anion exchanger 1, which is known to
swap negatively charged species (anions).
"Red blood cells were thought to be 'sacks' of hemoglobin," Stamler
said. "Instead, we've shown that there are two compartments of
hemoglobin and that the cell membrane actively regulates release of
NO from the cell. One compartment is in the middle, the other near
the membrane."
Furthermore, the scientists found that the cell membrane acts as a
reservoir of NO. In experiments in which red blood cells were
exposed to nitric oxide and then added to rings of blood vessel
muscle in the laboratory, the researchers found that the red blood
cells could store functional NO and release it to relax the
muscle.
"The idea had been that NO was consumed immediately by hemoglobin
when it went into the red blood cell," Stamler explained. "The
finding that NO has a lifespan inside the red blood cell shows that
things are not happening at all the way it was thought. Not only
are the reactions taking place differently than expected, but the
whole process is different."
Written by Joanna Downer.
